2018-2023 Global Inflammatory Bowel Disease Market Report (Status and Outlook)

September 2018 | 118 pages | ID: 25881A2374BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Inflammatory Bowel Disease market for 2018-2023.

Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.
Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient's disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn's disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine.
Over the next five years, LPI(LP Information) projects that Inflammatory Bowel Disease will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Inflammatory Bowel Disease market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Crohns disease
• Ulcerative colitis

Segmentation by application:

• Therapeutic
• Diagnostics

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Bristol-Myers Squibb Company
• Baxter International
• Johnson & Johnson
• Sanofi-Aventis
• Abbott Laboratories
• Pluristem Therapeutics
• Pfizer
• AstraZeneca
• Cephalon
• Amgen

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Inflammatory Bowel Disease market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Inflammatory Bowel Disease market by identifying its various subsegments.
• Focuses on the key global Inflammatory Bowel Disease players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Inflammatory Bowel Disease with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Inflammatory Bowel Disease submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Inflammatory Bowel Disease Market Size 2013-2023
  2.1.2 Inflammatory Bowel Disease Market Size CAGR by Region
2.2 Inflammatory Bowel Disease Segment by Type
  2.2.1 Crohns disease
  2.2.2 Ulcerative colitis
2.3 Inflammatory Bowel Disease Market Size by Type
  2.3.1 Global Inflammatory Bowel Disease Market Size Market Share by Type (2013-2018)
  2.3.2 Global Inflammatory Bowel Disease Market Size Growth Rate by Type (2013-2018)
2.4 Inflammatory Bowel Disease Segment by Application
  2.4.1 Therapeutic
  2.4.2 Diagnostics
2.5 Inflammatory Bowel Disease Market Size by Application
  2.5.1 Global Inflammatory Bowel Disease Market Size Market Share by Application (2013-2018)
  2.5.2 Global Inflammatory Bowel Disease Market Size Growth Rate by Application (2013-2018)

3 GLOBAL INFLAMMATORY BOWEL DISEASE BY PLAYERS

3.1 Global Inflammatory Bowel Disease Market Size Market Share by Players
  3.1.1 Global Inflammatory Bowel Disease Market Size by Players (2016-2018)
  3.1.2 Global Inflammatory Bowel Disease Market Size Market Share by Players (2016-2018)
3.2 Global Inflammatory Bowel Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INFLAMMATORY BOWEL DISEASE BY REGIONS

4.1 Inflammatory Bowel Disease Market Size by Regions
4.2 Americas Inflammatory Bowel Disease Market Size Growth
4.3 APAC Inflammatory Bowel Disease Market Size Growth
4.4 Europe Inflammatory Bowel Disease Market Size Growth
4.5 Middle East & Africa Inflammatory Bowel Disease Market Size Growth

5 AMERICAS

5.1 Americas Inflammatory Bowel Disease Market Size by Countries
5.2 Americas Inflammatory Bowel Disease Market Size by Type
5.3 Americas Inflammatory Bowel Disease Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Inflammatory Bowel Disease Market Size by Countries
6.2 APAC Inflammatory Bowel Disease Market Size by Type
6.3 APAC Inflammatory Bowel Disease Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Inflammatory Bowel Disease by Countries
7.2 Europe Inflammatory Bowel Disease Market Size by Type
7.3 Europe Inflammatory Bowel Disease Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Inflammatory Bowel Disease by Countries
8.2 Middle East & Africa Inflammatory Bowel Disease Market Size by Type
8.3 Middle East & Africa Inflammatory Bowel Disease Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL INFLAMMATORY BOWEL DISEASE MARKET FORECAST

10.1 Global Inflammatory Bowel Disease Market Size Forecast (2018-2023)
10.2 Global Inflammatory Bowel Disease Forecast by Regions
  10.2.1 Global Inflammatory Bowel Disease Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Inflammatory Bowel Disease Forecast by Type
10.8 Global Inflammatory Bowel Disease Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Bristol-Myers Squibb Company
  11.1.1 Company Details
  11.1.2 Inflammatory Bowel Disease Product Offered
  11.1.3 Bristol-Myers Squibb Company Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Bristol-Myers Squibb Company News
11.2 Baxter International
  11.2.1 Company Details
  11.2.2 Inflammatory Bowel Disease Product Offered
  11.2.3 Baxter International Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Baxter International News
11.3 Johnson & Johnson
  11.3.1 Company Details
  11.3.2 Inflammatory Bowel Disease Product Offered
  11.3.3 Johnson & Johnson Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Johnson & Johnson News
11.4 Sanofi-Aventis
  11.4.1 Company Details
  11.4.2 Inflammatory Bowel Disease Product Offered
  11.4.3 Sanofi-Aventis Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Sanofi-Aventis News
11.5 Abbott Laboratories
  11.5.1 Company Details
  11.5.2 Inflammatory Bowel Disease Product Offered
  11.5.3 Abbott Laboratories Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Abbott Laboratories News
11.6 Pluristem Therapeutics
  11.6.1 Company Details
  11.6.2 Inflammatory Bowel Disease Product Offered
  11.6.3 Pluristem Therapeutics Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Pluristem Therapeutics News
11.7 Pfizer
  11.7.1 Company Details
  11.7.2 Inflammatory Bowel Disease Product Offered
  11.7.3 Pfizer Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Pfizer News
11.8 AstraZeneca
  11.8.1 Company Details
  11.8.2 Inflammatory Bowel Disease Product Offered
  11.8.3 AstraZeneca Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 AstraZeneca News
11.9 Cephalon
  11.9.1 Company Details
  11.9.2 Inflammatory Bowel Disease Product Offered
  11.9.3 Cephalon Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Cephalon News
11.10 Amgen
  11.10.1 Company Details
  11.10.2 Inflammatory Bowel Disease Product Offered
  11.10.3 Amgen Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Amgen News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Inflammatory Bowel Disease
Figure Inflammatory Bowel Disease Report Years Considered
Figure Market Research Methodology
Figure Global Inflammatory Bowel Disease Market Size Growth Rate 2013-2023 ($ Millions)
Table Inflammatory Bowel Disease Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Crohns disease
Table Major Players of Ulcerative colitis
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Inflammatory Bowel Disease Market Size Market Share by Type (2013-2018)
Figure Global Inflammatory Bowel Disease Market Size Market Share by Type (2013-2018)
Figure Global Crohns disease Market Size Growth Rate
Figure Global Ulcerative colitis Market Size Growth Rate
Figure Inflammatory Bowel Disease Consumed in Therapeutic
Figure Global Inflammatory Bowel Disease Market: Therapeutic (2013-2018) ($ Millions)
Figure Global Therapeutic YoY Growth ($ Millions)
Figure Inflammatory Bowel Disease Consumed in Diagnostics
Figure Global Inflammatory Bowel Disease Market: Diagnostics (2013-2018) ($ Millions)
Figure Global Diagnostics YoY Growth ($ Millions)
Table Global Inflammatory Bowel Disease Market Size by Application (2013-2018) ($ Millions)
Table Global Inflammatory Bowel Disease Market Size Market Share by Application (2013-2018)
Figure Global Inflammatory Bowel Disease Market Size Market Share by Application (2013-2018)
Figure Global Inflammatory Bowel Disease Market Size in Therapeutic Growth Rate
Figure Global Inflammatory Bowel Disease Market Size in Diagnostics Growth Rate
Table Global Inflammatory Bowel Disease Revenue by Players (2016-2018) ($ Millions)
Table Global Inflammatory Bowel Disease Revenue Market Share by Players (2016-2018)
Figure Global Inflammatory Bowel Disease Revenue Market Share by Players in 2017
Table Global Inflammatory Bowel Disease Key Players Head office and Products Offered
Table Inflammatory Bowel Disease Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Inflammatory Bowel Disease Market Size by Regions 2013-2018 ($ Millions)
Table Global Inflammatory Bowel Disease Market Size Market Share by Regions 2013-2018
Figure Global Inflammatory Bowel Disease Market Size Market Share by Regions 2013-2018
Figure Americas Inflammatory Bowel Disease Market Size 2013-2018 ($ Millions)
Figure APAC Inflammatory Bowel Disease Market Size 2013-2018 ($ Millions)
Figure Europe Inflammatory Bowel Disease Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Inflammatory Bowel Disease Market Size 2013-2018 ($ Millions)
Table Americas Inflammatory Bowel Disease Market Size by Countries (2013-2018) ($ Millions)
Table Americas Inflammatory Bowel Disease Market Size Market Share by Countries (2013-2018)
Figure Americas Inflammatory Bowel Disease Market Size Market Share by Countries in 2017
Table Americas Inflammatory Bowel Disease Market Size by Type (2013-2018) ($ Millions)
Table Americas Inflammatory Bowel Disease Market Size Market Share by Type (2013-2018)
Figure Americas Inflammatory Bowel Disease Market Size Market Share by Type in 2017
Table Americas Inflammatory Bowel Disease Market Size by Application (2013-2018) ($ Millions)
Table Americas Inflammatory Bowel Disease Market Size Market Share by Application (2013-2018)
Figure Americas Inflammatory Bowel Disease Market Size Market Share by Application in 2017
Figure United States Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Canada Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Table APAC Inflammatory Bowel Disease Market Size by Countries (2013-2018) ($ Millions)
Table APAC Inflammatory Bowel Disease Market Size Market Share by Countries (2013-2018)
Figure APAC Inflammatory Bowel Disease Market Size Market Share by Countries in 2017
Table APAC Inflammatory Bowel Disease Market Size by Type (2013-2018) ($ Millions)
Table APAC Inflammatory Bowel Disease Market Size Market Share by Type (2013-2018)
Figure APAC Inflammatory Bowel Disease Market Size Market Share by Type in 2017
Table APAC Inflammatory Bowel Disease Market Size by Application (2013-2018) ($ Millions)
Table APAC Inflammatory Bowel Disease Market Size Market Share by Application (2013-2018)
Figure APAC Inflammatory Bowel Disease Market Size Market Share by Application in 2017
Figure China Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Japan Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Korea Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure India Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Australia Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Table Europe Inflammatory Bowel Disease Market Size by Countries (2013-2018) ($ Millions)
Table Europe Inflammatory Bowel Disease Market Size Market Share by Countries (2013-2018)
Figure Europe Inflammatory Bowel Disease Market Size Market Share by Countries in 2017
Table Europe Inflammatory Bowel Disease Market Size by Type (2013-2018) ($ Millions)
Table Europe Inflammatory Bowel Disease Market Size Market Share by Type (2013-2018)
Figure Europe Inflammatory Bowel Disease Market Size Market Share by Type in 2017
Table Europe Inflammatory Bowel Disease Market Size by Application (2013-2018) ($ Millions)
Table Europe Inflammatory Bowel Disease Market Size Market Share by Application (2013-2018)
Figure Europe Inflammatory Bowel Disease Market Size Market Share by Application in 2017
Figure Germany Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure France Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure UK Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Italy Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Russia Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Spain Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Inflammatory Bowel Disease Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Inflammatory Bowel Disease Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Inflammatory Bowel Disease Market Size Market Share by Countries in 2017
Table Middle East & Africa Inflammatory Bowel Disease Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Inflammatory Bowel Disease Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Inflammatory Bowel Disease Market Size Market Share by Type in 2017
Table Middle East & Africa Inflammatory Bowel Disease Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Inflammatory Bowel Disease Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Inflammatory Bowel Disease Market Size Market Share by Application in 2017
Figure Egypt Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Israel Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Inflammatory Bowel Disease Market Size Growth 2013-2018 ($ Millions)
Figure Global Inflammatory Bowel Disease arket Size Forecast (2018-2023) ($ Millions)
Table Global Inflammatory Bowel Disease Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Inflammatory Bowel Disease Market Size Market Share Forecast by Regions
Figure Americas Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure APAC Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Europe Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure United States Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Canada Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Mexico Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Brazil Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure China Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Japan Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Korea Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure India Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Australia Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Germany Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure France Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure UK Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Italy Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Russia Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Spain Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Egypt Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure South Africa Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Israel Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure Turkey Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Figure GCC Countries Inflammatory Bowel Disease Market Size 2018-2023 ($ Millions)
Table Global Inflammatory Bowel Disease Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Inflammatory Bowel Disease Market Size Market Share Forecast by Type (2018-2023)
Table Global Inflammatory Bowel Disease Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Inflammatory Bowel Disease Market Size Market Share Forecast by Application (2018-2023)
Table Bristol-Myers Squibb Company Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Company Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Company Inflammatory Bowel Disease Market Share (2016-2018)
Table Baxter International Basic Information, Head Office, Major Market Areas and Its Competitors
Table Baxter International Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure Baxter International Inflammatory Bowel Disease Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table Johnson & Johnson Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure Johnson & Johnson Inflammatory Bowel Disease Market Share (2016-2018)
Table Sanofi-Aventis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanofi-Aventis Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure Sanofi-Aventis Inflammatory Bowel Disease Market Share (2016-2018)
Table Abbott Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table Abbott Laboratories Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Market Share (2016-2018)
Table Pluristem Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pluristem Therapeutics Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure Pluristem Therapeutics Inflammatory Bowel Disease Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure Pfizer Inflammatory Bowel Disease Market Share (2016-2018)
Table AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure AstraZeneca Inflammatory Bowel Disease Market Share (2016-2018)
Table Cephalon Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cephalon Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure Cephalon Inflammatory Bowel Disease Market Share (2016-2018)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Inflammatory Bowel Disease Revenue and Gross Margin (2016-2018)
Figure Amgen Inflammatory Bowel Disease Market Share (2016-2018)